| Financial Year |
March 31 2023 |
| Monetary Funds |
1,631,297,835.22 |
| Held-for-trading Financial Assets |
113,428,550.00 |
| Notes Receivable |
30,654,192.19 |
| Accounts Receivable |
1,550,035,352.02 |
| Advances to Suppliers |
59,916,289.75 |
| Other Receivables |
11,566,752.61 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
866,027,934.59 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
57,223,810.06 |
| Total Current Assets |
4,544,649,365.10 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
744,592,111.61 |
| Investment Properties |
-- |
| Fixed Assetes |
5,406,120,523.70 |
| Under-construction Projects |
1,025,400,425.38 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
250,318,299.78 |
| R&D expenses |
26,704,181.67 |
| Goodwill |
262,729,911.83 |
| Long-Term Deferred and Prepaid Expenses |
165,295,431.60 |
| Deferred Income Tax Assets |
96,765,733.69 |
| Other Non-Current Assets |
417,002,544.78 |
| Sub-Total of Non-Current Assets |
8,415,221,528.64 |
| Total Assets |
12,959,870,893.74 |
| Short-Term Loans |
735,755,775.60 |
| Trading Financial liabilities |
-- |
| Notes Payable |
888,266,702.34 |
| Accounts Payable |
1,032,361,983.18 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
113,612,324.25 |
| Taxes Payable |
27,599,011.36 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
34,356,172.87 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
2,339,000.45 |
| Other Current Liabilities |
1,868,443.22 |
| Sub-Total of Current Liabilities |
3,399,296,195.81 |
| Long-term Loans |
-- |
| Bonds Payable |
258,475,831.13 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
9,344,960.00 |
| Deferred Income Tax Liabilities |
45,625,819.12 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
703,656,651.11 |
| Total Liabilities |
4,102,952,846.92 |
| Paid-In Capital(Or Share Stock) |
2,454,918,133.00 |
| Capital Surplus |
1,117,491,833.08 |
| Surplus Reserve |
504,324,205.06 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
4,257,111,266.95 |
| Minority Stockholder's Interest |
486,342,161.67 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
8,370,575,885.15 |
| Owner's Equity（Stockholder's Equity） |
8,856,918,046.82 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
12,959,870,893.74 |
